Sanofi

An ASCO Bio-Pharma Catalyst Trade With A Promising Leukemia Drug
Seeking Alpha
Wed, 05/9/12 - 10:19 am
leukemia
ASCO
Sunesis
Bristol-Myers Squibb
vosaroxin
Ariad Pharmaceuticals
Sanofi
AML
Novartis
Bright Future Ahead Of Abbott Despite Mounting Competition
Seeking Alpha
Tue, 05/8/12 - 07:17 pm
Abbott Laboratories
Merck
Nestle
Pfizer
Roche
Sanofi
Roche's Pain May Be Merck's Gain
Seeking Alpha
Mon, 05/7/12 - 11:16 am
Roche
Merck
dalcetrapib
Abbott Laboratories
Bristol-Myers Squibb
Gilead
Eli Lilly
Pfizer
Sanofi
Illumina
Eli Lilly's Valuation May Prove To Be A Good Investment Opportunity
Seeking Alpha
Mon, 05/7/12 - 11:13 am
Eli Lilly
Amylin
GSK
Novo Nordisk
Pfizer
Sanofi
Diving for Dividend Growth in Big Pharma
Motley Fool
Fri, 05/4/12 - 10:40 am
dividends
GSK
Novartis
AstraZeneca
Sanofi
Abbott Laboratories
Roche
Bayer
Sanofi first quarter profit climbs 13% on Genzyme, Lantus
The Star Ledger, NJ
Sat, 04/28/12 - 12:55 pm
Sanofi
earnings
Sanofi-Aventis's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Seeking Alpha
Sat, 04/28/12 - 12:28 pm
Sanofi
earnings
Sanofi First-Quarter Net Climbs 13% on Genzyme, Lantus
Bloomberg
Fri, 04/27/12 - 10:30 am
earnings
Sanofi
The Drama Continues At Amylin Pharmaceuticals: Takeover Still Likely
Seeking Alpha
Fri, 04/27/12 - 10:16 am
Amylin
M&A
Bristol-Myers Squibb
Sanofi
Eli Lilly
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wed, 04/18/12 - 12:11 pm
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron
Eli Lilly Will Sink If Solanezumab Fails
Seeking Alpha
Wed, 04/18/12 - 11:42 am
solanezumab
Eli Lilly
GSK
JNJ
Pfizer
Sanofi
Alzheimer's disease
A Reasoned Case For Avanafil Approval
Seeking Alpha
Wed, 04/18/12 - 11:40 am
Avanafil
Vivus
Pfizer
Sanofi
erectile dysfunction
Questcor Will Skyrocket Into 2013
Seeking Alpha
Mon, 04/16/12 - 04:03 pm
Questcor
Acthar
Sanofi
Novartis
How Will Dendreon be Affected by the STOCK Act?
Motley Fool
Mon, 04/16/12 - 11:30 am
STOCK Act
Dendreon
insider trading
GSK
Pfizer
Novartis
Sanofi
U.S. court invalidates two Sanofi Taxotere patents
Reuters
Wed, 04/11/12 - 11:59 am
patents
Sanofi
Taxotere
Dendreon: Healthy Competition Will Boost Profits
Seeking Alpha
Tue, 04/10/12 - 11:15 am
Dendreon
Provenge
prostate cancer
Abbott Laboratories
Bristol-Myers Squibb
JNJ
Sanofi
Arena Pharmaceuticals: A Stock For Aggressive Investors
Seeking Alpha
Mon, 04/9/12 - 11:58 am
Arena Pharmaceuticals
Abbott Laboratories
GSK
Sanofi
Priority Review for Zaltrap
Yahoo/Zacks
Thu, 04/5/12 - 09:12 pm
Zaltrap
Regeneron
Sanofi
colorectal cancer
Teva Active on the Generics Front
Yahoo/Zacks
Thu, 04/5/12 - 09:06 pm
generics
Teva Pharmaceuticals
Sanofi
AstraZeneca
Avapro
Avalide
Lexapro
Forest Labs
Seroquel
Sanofi buys U.S. animal vaccine firm
Reuters
Mon, 04/2/12 - 11:56 am
M&A
animal health
Sanofi
Newport Laboratories

Pages